跳至主要内容
临床试验/CTRI/2024/09/073456
CTRI/2024/09/073456尚未招募不适用

A Comparative study to evaluate the efficacy and safety of Olanzapine and Cariprazine in patients with Bipolar disorder

Dr Mukesh kumar1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2024年9月16日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
72
试验地点
1
主要终点
Quality of life

研究概览

简要总结

To campare the efficacy and safety of Olanzapine 5mg once a day and Cariprazine 1.5mg once a day in patients of Biploar Disorder .These study is the Prospective Randomized Double Blind Parallel group drug study.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Double

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1 Patients or attendant giving written informed consent 2 Male and female patients who met diagnostic criteria for bipolar disorder and a major depressive episode as defined by DSM-IV 3 Patients will be required to have been in a depressive episode.

排除标准

  • 1 Patient not willing to participate in the study.
  • 2 Unstable medical illness 3 History of diabetes 4 Recent substance dependence.
  • 5 History of serious psychiatric illness other than bipolar disorder.
  • •depot antipsychotics or central nervous system medications other than mood stabilisers •Current rapid-cycling mood disturbance.

结局指标

主要结局

Quality of life

时间窗: Baseline, 2weeks, 4weeks,

次要结局

  • Adverse drug reaction of drugs(Every 2 weeks for 4 weeks.)

研究者

发起方
Dr Mukesh kumar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Anil kumar

Baba Raghav Das Medical college.Gorakhpur

研究点 (1)

Loading locations...

相似试验